Septerna (SEPN) Other Non-Current Assets (2023 - 2026)
Septerna's quarterly Other Non-Current Assets came in at $773000.0 in Q1 2026, down 14.59% year-on-year from $905000.0 in Q1 2025, and down 14.59% quarter-over-quarter from $905000.0 in Q4 2025.
Septerna has reported Other Non-Current Assets for 4 years, with the latest figure at $773000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 14.59% year-over-year to $773000.0; the trailing twelve-month figure through Mar 2026 stood at $773000.0 (down 14.59% YoY), and the FY2025 full-year result was $905000.0, up 238.95% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $773000.0, down from $905000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $3.5 million in Q3 2024, with the low at $267000.0 in Q4 2024.
- Average Other Non-Current Assets over 4 years is $1.1 million, with a median of $905000.0 recorded in 2023.
- Year-over-year, Other Non-Current Assets surged 284.42% in 2024 and slumped 73.99% in 2025.
- Tracing SEPN's Other Non-Current Assets over 4 years: stood at $905000.0 in 2023, then tumbled by 70.5% to $267000.0 in 2024, then surged by 238.95% to $905000.0 in 2025, then retreated by 14.59% to $773000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $773000.0 (Q1 2026), $905000.0 (Q4 2025), and $905000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | 773,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 773,000.00 |
| Dec 31, 2025 | 905,000.00 |
| Sep 30, 2025 | 905,000.00 |
| Jun 30, 2025 | 905,000.00 |
| Mar 31, 2025 | 905,000.00 |
| Dec 31, 2024 | 267,000.00 |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | 905,000.00 |
| Mar 31, 2024 | 905,000.00 |
| Dec 31, 2023 | 905,000.00 |
| Sep 30, 2023 | 905,000.00 |